​

Artelo Biosciences (ARTL) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ARTL Stock Rating

Artelo Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

ARTL Price Target Upside V Benchmarks

TypeNameUpside
StockArtelo Biosciences-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.14$4.14$4.14
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26--1--1
Jan, 26--1--1
Dec, 25--1--1
Nov, 25--1--1
Oct, 25--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 01, 2024EF HuttonBuyinitialise
Nov 01, 2021H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.49$-3.14$-3.05$-12.52---
Avg Forecast$-3.04$-2.56$-1.78$-0.80$-0.57$-0.46$0.35
High Forecast$-3.04$-2.24$-1.21$-0.40$-0.37$-0.25$0.35
Low Forecast$-3.04$-2.86$-2.34$-1.21$-0.84$-0.73$0.35
Surprise %14.80%22.66%71.35%1465.00%---

Revenue Forecast

$49M $49M $49M $50M $50M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast-----$49.29M$49.78M
High Forecast-----$49.29M$49.78M
Low Forecast-----$49.29M$49.78M
Surprise %-------

Net Income Forecast

$-15M $-11M $-7M $-3M $1M $5M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-10.08M$-9.29M$-9.83M$-12.88M---
Avg Forecast$-8.62M$-7.23M$-5.04M$-2.27M$-1.70M$-1.39M$991.55K
High Forecast$-8.62M$-6.35M$-3.44M$-1.13M$-1.04M$-703.18K$991.55K
Low Forecast$-8.62M$-8.11M$-6.63M$-3.42M$-2.37M$-2.08M$991.55K
Surprise %16.95%28.52%95.13%466.49%---

ARTL Forecast FAQ

Is Artelo Biosciences stock a buy?

Artelo Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Artelo Biosciences is a favorable investment for most analysts.

What is Artelo Biosciences's price target?

Artelo Biosciences's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.14.

How does Artelo Biosciences stock forecast compare to its benchmarks?

Artelo Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Artelo Biosciences over the past three months?

  • February 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Artelo Biosciences’s EPS forecast?

Artelo Biosciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.57, marking a -95.45% decrease from the reported $-12.52 in 2025. Estimates for the following years are $-0.46 in 2027, and $0.35 in 2028.

What is Artelo Biosciences’s revenue forecast?

Artelo Biosciences's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $49.29M, and $49.78M for 2028.

What is Artelo Biosciences’s net income forecast?

Artelo Biosciences's net income forecast for the fiscal year ending in December 2026 stands at $-1.704M, representing a -86.77% decrease from the reported $-12.879M in 2025. Projections indicate $-1.392M in 2027, and $991.55K in 2028.